Correlation Between OnKure Therapeutics, and BCE

Can any of the company-specific risk be diversified away by investing in both OnKure Therapeutics, and BCE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OnKure Therapeutics, and BCE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OnKure Therapeutics, and BCE Inc, you can compare the effects of market volatilities on OnKure Therapeutics, and BCE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OnKure Therapeutics, with a short position of BCE. Check out your portfolio center. Please also check ongoing floating volatility patterns of OnKure Therapeutics, and BCE.

Diversification Opportunities for OnKure Therapeutics, and BCE

0.65

Correlation Coefficient

OnKure Therapeutics,  BCE

Poor diversification

The 3 months correlation between OnKure and BCE is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding OnKure Therapeutics, and BCE Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BCE Inc and OnKure Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OnKure Therapeutics, are associated (or correlated) with BCE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BCE Inc has no effect on the direction of OnKure Therapeutics, i.e., OnKure Therapeutics, and BCE go up and down completely randomly.

Pair Corralation between OnKure Therapeutics, and BCE

Given the investment horizon of 90 days OnKure Therapeutics, is expected to under-perform the BCE. In addition to that, OnKure Therapeutics, is 2.85 times more volatile than BCE Inc. It trades about -0.16 of its total potential returns per unit of risk. BCE Inc is currently generating about -0.39 per unit of volatility. If you would invest  3,412  in BCE Inc on September 23, 2024 and sell it today you would lose (1,096) from holding BCE Inc or give up 32.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

OnKure Therapeutics,  vs.  BCE Inc

OnKure Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

BCE Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BCE Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with OnKure Therapeutics, and BCE

The main advantage of trading using opposite OnKure Therapeutics, and BCE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OnKure Therapeutics, position performs unexpectedly, BCE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCE will offset losses from the drop in BCE's long position.

The idea behind OnKure Therapeutics, and BCE Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.